Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease Psychosis”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Not applicableStudy completedNCT00001258
What this trial is testing

Studies of Frontal Lobe Brain Functioning in Schizophrenia

Who this might be right for
Healthy SubjectsSchizophreniaParkinson Disease
National Institute of Mental Health (NIMH) 1,039
Large-scale testing (Phase 3)Study completedNCT03325556
What this trial is testing

Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis

Who this might be right for
Dementia-related Psychosis
ACADIA Pharmaceuticals Inc. 392
Not applicableEnded earlyNCT03152292
What this trial is testing

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

Who this might be right for
Parkinson Disease Psychosis
ACADIA Pharmaceuticals Inc. 764
Not applicableUnknownNCT04579887
What this trial is testing

Presence Hallucination in Parkinson's Disease

Who this might be right for
Parkinson Disease Psychosis
Olaf Blanke 10
Post-approval studies (Phase 4)Study completedNCT00095810
What this trial is testing

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychoses
Otsuka Pharmaceutical Development & Commercialization, Inc. 50
Early research (Phase 1)Not Yet RecruitingNCT06388551
What this trial is testing

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 60
Post-approval studies (Phase 4)Looking for participantsNCT05357612
What this trial is testing

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Who this might be right for
Neurodegenerative DiseasesParkinson DiseaseParkinson Disease Psychosis
Vanderbilt University Medical Center 75
Very early researchWithdrawnNCT05796167
What this trial is testing

Pimavanserin for Sleep in Parkinson Disease

Who this might be right for
Parkinson Disease
State University of New York - Downstate Medical Center
Testing effectiveness (Phase 2)Study completedNCT02969369
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 39
Not applicableStudy completedNCT00001320
What this trial is testing

Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients

Who this might be right for
HealthySchizophrenia
National Institute of Mental Health (NIMH) 265
Not applicableLooking for participantsNCT03217110
What this trial is testing

Cerebellar Stimulation and Cognitive Control

Who this might be right for
SchizophreniaAutism Spectrum DisorderBipolar Disorder+2 more
Krystal Parker, PhD 200
Not applicableLooking for participantsNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Not applicableStudy completedNCT00360633
What this trial is testing

Psychiatric and Cognitive Manifestations of Parkinson's Disease

Who this might be right for
Parkinson's Disease
NYU Langone Health 36
Testing effectiveness (Phase 2)Study completedNCT02818777
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Colorado, Denver 13
Not applicableStudy completedNCT00024622
What this trial is testing

PET Scanning in Parkinson s Disease

Who this might be right for
SchizophreniaParkinson's Disease
National Institute of Mental Health (NIMH) 502
Not applicableLooking for participantsNCT07509125
What this trial is testing

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

Who this might be right for
Alzheimer Dementia (AD)ALS - Amyotrophic Lateral SclerosisParkinson s Disease+7 more
Universitaire Ziekenhuizen KU Leuven 300
Post-approval studies (Phase 4)Looking for participantsNCT04373317
What this trial is testing

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Who this might be right for
Parkinson's Disease Psychosis
VA Office of Research and Development 358
Not applicableUnknownNCT04399096
What this trial is testing

Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of Hallucinations

Who this might be right for
SchizophreniaParkinson DiseaseHallucinations
University of Cambridge 500
Early research (Phase 1)Study completedNCT06450184
What this trial is testing

Bioequivalence Study of Pimavanserin 34 mg Capsule

Who this might be right for
Parkinson Disease Psychosis
Humanis Saglık Anonim Sirketi 32
Post-approval studies (Phase 4)Looking for participantsNCT05590637
What this trial is testing

Comparing Antipsychotic Medications in LBD Over Time

Who this might be right for
Parkinson's Disease PsychosisDementia With Lewy Bodies
The University of Texas Health Science Center at San Antonio 94
Load More Results